PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
39,915,363
Share change
+1,651,186
Total reported value
$1,312,819,295
Price per share
$32.89
Number of holders
81
Value change
+$51,865,975
Number of buys
47
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q1 2021

As of 31 Mar 2021, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,915,363 shares. The largest 10 holders included ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Euclidean Capital LLC, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.